Ethical Compliance

SUN PHARMA ADV.RES.CO.LTD
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
small
Revenue
27.3%
Debt
9.1%
Liquidity
30.2%
Revenue
Debt
Liquidity
27.3%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
Sale of Services - Licence Fees / Royalty on Technology / R&d Services | ₹75.55 |
Other Income | ₹0.81 |
Questionable
INR Crores
Non Compliant
INR Crores
interest & other | ₹28.66 |
INR Crores
Revenue from Questionable Sources: | ₹0.00 |
Revenue from Non Compliant Sources: | ₹28.66 |
Total: | ₹28.66 |
Total Revenue: | ₹105.01 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹28.66
₹105.01
= 27.3%
non-compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.